These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4285307)

  • 1. A calcifying topical reaction to mast cell depletors in the rat.
    Dieudonné JM
    Experientia; 1964 Apr; 20(4):209-10. PubMed ID: 4285307
    [No Abstract]   [Full Text] [Related]  

  • 2. EFFECT OF CYPROHEPTADINE ON A TOPICAL CALCIFICATION IN THE RAT.
    DIEUDONNE JM
    Can J Physiol Pharmacol; 1964 May; 42():349-52. PubMed ID: 14324165
    [No Abstract]   [Full Text] [Related]  

  • 3. Protamine-like property of compounds 48/80 and stilbamidine and their action on mast cells.
    MOTA I; BERALDO WT; JUNQUEIRA CU
    Proc Soc Exp Biol Med; 1953 Jul; 83(3):455-7. PubMed ID: 13088875
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective release of histamine from rat mast cells by several drugs.
    Ellis HV; Johnson AR; Moran NC
    J Pharmacol Exp Ther; 1970 Dec; 175(3):627-31. PubMed ID: 4099125
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of mast cell depletors on vascular reactivity in the mesenteric microcirculation.
    Weiner R
    Bibl Anat; 1967; 9():17-21. PubMed ID: 4291514
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-induced resistance to tissue calcification.
    Selye H; Tuchweber B; Caruso PL
    J Pharm Sci; 1965 Jun; 54(6):832-7. PubMed ID: 4284892
    [No Abstract]   [Full Text] [Related]  

  • 7. TOPICAL RESISTANCE TO MASTOCALCERGY.
    SELYE H; TUCHWEBER B; CARUSO PL
    J Pharmacol Exp Ther; 1964 Nov; 146():252-7. PubMed ID: 14236937
    [No Abstract]   [Full Text] [Related]  

  • 8. Protamine and mast-cell-mediated angiogenesis in the rat.
    Jakobsson A; Sörbo J; Norrby K
    J Exp Pathol (Oxford); 1990 Apr; 71(2):209-17. PubMed ID: 1691920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of human conjunctival mast cell degranulation in response to compound 48/80.
    Udell IJ; Kenyon KR; Hanninen LA; Abelson MB
    Acta Ophthalmol Suppl (1985); 1989; 192():154-61. PubMed ID: 2554645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemia and the activity of compound 48-80 in the rat.
    Sacra PJ; Adamkiewicz VW
    Arch Int Pharmacodyn Ther; 1965 Aug; 156(2):255-60. PubMed ID: 5868936
    [No Abstract]   [Full Text] [Related]  

  • 11. PROTECTION AGAINST NEUROTROPIC MASTOCALCERGY.
    SELYE H; TUCHWEBER B; CARUSO PL
    Exp Neurol; 1964 Nov; 10():451-61. PubMed ID: 14228402
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the question of mast cell degranulation by compound 48-80. Tachyphylaxis of isolated mast cells against 48-80, inhibition of degranulation by heparinoids, modification of tachyphylaxis by protamine].
    Schuster J; Kunze J
    Arzneimittelforschung; 1969 Apr; 19(4):589-91. PubMed ID: 4182108
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipase release induced by Compound 48/80 in rat and perfused rat heart.
    Ho RJ; Aktin E; Meng HC
    Am J Physiol; 1966 Feb; 210(2):299-304. PubMed ID: 5901467
    [No Abstract]   [Full Text] [Related]  

  • 14. EFFECT OF HISTAMINE, SEROTONIN AND CATECHOLAMINE DEPLETORS ON THE CAPILLARIES IN THE RAT SKIN.
    GOEZSY B; KATO L
    Arch Int Pharmacodyn Ther; 1964 Mar; 148():243-54. PubMed ID: 14171753
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuum of historical controversies regarding the structural-functional relationship of the glomerular ultrafiltration unit.
    Kanwar YS
    Am J Physiol Renal Physiol; 2015 Mar; 308(5):F420-4. PubMed ID: 25503736
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative correlation between degranulation and histamine release following exposure of rat mast cells to compound 48-80 in vitro.
    Nósal R; Slorach SA; Uvnäs B
    Acta Physiol Scand; 1970 Oct; 80(2):215-21. PubMed ID: 4097580
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug interaction studies on amphibian vasoconstrictor responses to mast cell degranulators.
    Gambhir SS; Das PK
    Indian J Med Res; 1980 Jun; 71():933-9. PubMed ID: 6252102
    [No Abstract]   [Full Text] [Related]  

  • 18. Histamine release from rat peritoneal mast cells: inhibition by colchicine and potentiation by deuterium oxide.
    Gillespie E; Levine RJ; Malawista SE
    J Pharmacol Exp Ther; 1968 Nov; 164(1):158-65. PubMed ID: 4177465
    [No Abstract]   [Full Text] [Related]  

  • 19. [The pharmacologic characteristics of otoline (a histamine liberator of the compound 48-80 type].
    Dubovik BV; Shadurskiĭ KS; Etlis VS; Il'iuchenok TIu; Frigidova LM
    Farmakol Toksikol; 1973; 36(5):614-8. PubMed ID: 4132661
    [No Abstract]   [Full Text] [Related]  

  • 20. The release of histamine, heparin and granule protein from rat mast cells treated with compound 48-80 in vitro.
    Fillion GM; Slorach SA; Uvnäs B
    Acta Physiol Scand; 1970 Apr; 78(4):547-60. PubMed ID: 4194583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.